Cargando…

Cancer-testis antigen expression and immunogenicity in AL amyloidosis

Light-chain amyloidosis (AL) is a plasma cell dyscrasia closely related to multiple myeloma. In multiple myeloma, the cancer-testis antigens (CTAs) CT7 (MAGE-C1), CT10 (MAGE-C2) and MAGE-A CTAs are expressed in up to 80% of cases. In this study, we investigated the expression and immunogenicity of s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rosenzweig, M A, Landau, H, Seldin, D, O'Hara, C, Girnius, S, Hanson, N, Frosina, D, Sedrak, C, Arcila, M, Comenzo, R L, Giralt, S, Gnjatic, S, Jungbluth, A A, Koehne, G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2012
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3461704/ https://www.ncbi.nlm.nih.gov/pubmed/22983433 http://dx.doi.org/10.1038/bcj.2012.32

Ejemplares similares

Light Chain Amyloidosis: Patient Experience Survey from the Amyloidosis Research Consortium
por: Lousada, Isabelle, et al.
Publicado: (2015)

Long-term event-free and overall survival after risk-adapted melphalan and SCT for systemic light chain amyloidosis
por: Landau, H, et al.
Publicado: (2017)

Patient experience with hereditary and senile systemic amyloidoses: a survey from the Amyloidosis Research Consortium
por: Lousada, Isabelle, et al.
Publicado: (2015)

An overview of cancer/testis antigens expression in classical Hodgkin's lymphoma (cHL) identifies MAGE-A family and MAGE-C1 as the most frequently expressed antigens in a set of Brazilian cHL patients
por: Inaoka, Riguel J, et al.
Publicado: (2011)

Preclinical Development of siRNA Therapeutics for AL Amyloidosis
por: Hovey, Beth M., et al.
Publicado: (2011)

Light chain (AL) amyloidosis: update on diagnosis and management
por: Rosenzweig, Michael, et al.
Publicado: (2011)

NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

Correction: NY-ESO-1 Cancer Testis Antigen Demonstrates High Immunogenicity in Triple Negative Breast Cancer
por: Ademuyiwa, Foluso O., et al.
Publicado: (2012)

CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
por: Almeida, Luiz Gonzaga, et al.
Publicado: (2009)

AL Amyloidosis: Current Chemotherapy and Immune Therapy Treatment Strategies: JACC: CardioOncology State-of-the-Art Review
por: Bianchi, Giada, et al.
Publicado: (2021)

Predictors of Mortality in Light Chain Cardiac Amyloidosis with Heart Failure
por: Tahir, Usman A., et al.
Publicado: (2019)

Serological identification of Tektin5 as a cancer/testis antigen and its immunogenicity
por: Hanafusa, Tadashi, et al.
Publicado: (2012)

Venetoclax induces deep hematologic remissions in t(11;14) relapsed/refractory AL amyloidosis
por: Premkumar, Vikram J., et al.
Publicado: (2021)

A randomized phase 3 study of ixazomib–dexamethasone versus physician’s choice in relapsed or refractory AL amyloidosis
por: Dispenzieri, Angela, et al.
Publicado: (2021)

Evaluation of cancer testis antigen (CT10, PRAME) and MHC I expression in high grade urothelial carcinoma of the bladder
por: Hodgson, Anjelica, et al.
Publicado: (2019)

Cancer testis antigen PASD1 expression and immunogenicity in human colorectal cancer and polyps
por: SUKOR, Nur Fazilah, et al.
Publicado: (2022)

A Case of T-Cell Large Granular Lymphocytic Leukemia and Renal Immunoglobulin Heavy Chain Amyloidosis
por: Fu, Julie, et al.
Publicado: (2019)

P56 SURVIVAL BENEFIT OF BIRTAMIMAB IN MAYO STAGE IV AL AMYLOIDOSIS IN THE PHASE 3 VITAL STUDY WAS CONSISTENT ACROSS ALL KEY BASELINE VARIABLES
por: Gertz, M., et al.
Publicado: (2023)

Birtamimab plus standard of care in light-chain amyloidosis: the phase 3 randomized placebo-controlled VITAL trial
por: Gertz, Morie A., et al.
Publicado: (2023)

Cancer Testis Antigens and Immunotherapy: Expression of PRAME Is Associated with Prognosis in Soft Tissue Sarcoma
por: Albertsmeier, Markus, et al.
Publicado: (2020)

Cancer Testis Antigen, NOL4, Is an Immunogenic Antigen Specifically Expressed in Small-Cell Lung Cancer
por: Kim, Ye-Rin, et al.
Publicado: (2021)

Circulating Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Cardiac Amyloidosis
por: Tanaka, Komei, et al.
Publicado: (2013)

Unraveling a rare cause of spinal stenosis: Coexistent AL and ATTR amyloidosis involving the ligamentum flavum
por: Godara, Amandeep, et al.
Publicado: (2022)

Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p
por: Wong, Sandy W., et al.
Publicado: (2018)

LKB1 Is an Essential Regulator of Spermatozoa Release during Spermiation in the Mammalian Testis
por: Denison, Fiona C., et al.
Publicado: (2011)

Cancer testis antigens expression in mesothelioma: role of DNA methylation and bioimmunotherapeutic implications
por: Sigalotti, L, et al.
Publicado: (2002)

Amyloidosis with Cardiac Involvement: Identification, Characterization, and Management
por: Jamal, Faizi, et al.
Publicado: (2021)

Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications
por: Balafoutas, Dimitrios, et al.
Publicado: (2013)

Rationale, application and clinical qualification for NT-proBNP as a surrogate end point in pivotal clinical trials in patients with AL amyloidosis
por: Merlini, G, et al.
Publicado: (2016)

Outcomes by Cardiac Stage in Patients With Newly Diagnosed AL Amyloidosis: Phase 3 ANDROMEDA Trial
por: Minnema, Monique C., et al.
Publicado: (2022)

Organ response in patients with AL amyloidosis treated with NEOD001, an amyloid‐directed monoclonal antibody
por: gertz, morie a., et al.
Publicado: (2016)

Amyloidosis
por: Reddy, D. J.
Publicado: (1951)

Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders
por: Landau, Meytal, et al.
Publicado: (2011)

Testis sperm extraction
por: Janosek-Albright, Kirsten J.C., et al.
Publicado: (2015)

Primary Systemic Amyloidosis
por: Wahi, P. N., et al.
Publicado: (1950)

Syphilis of the Testis
por: Ravogli, A.
Publicado: (1917)

Disease progression in cardiac transthyretin amyloidosis is indicated by serial calculation of National Amyloidosis Centre transthyretin amyloidosis stage
por: Law, Steven, et al.
Publicado: (2020)

Cancer testis antigen and immunotherapy
por: Krishnadas, Deepa Kolaseri, et al.
Publicado: (2013)

An interesting case of renal amyloidosis
por: Hajra, A., et al.
Publicado: (2016)

Induced Pluripotent Stem Cell Modeling of Multisystemic, Hereditary Transthyretin Amyloidosis
por: Leung, Amy, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1pdq325qpucfvu9s4li9nkv6d5